Michael Adams, MD
Interventional Pain Medicine · Mena, ARNPI 1407098890
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,163 of the $5,776 with a category attached, or 72.1%. Medtronic accounts for 66.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $3,101 and has fallen 64.5% since, to $1,101 in 2025.
Across 77 payments — averaging $75.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Stryker$949
- Boston Scientific$219
- AbbVie$167
- Amgen$138
- Collegium Pharmaceutical, Inc.$130
- plus $306 from 7 others
What the payments were for
- Travel & lodging$4,16372%
- Food & beverage$1,61328%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 28 | $3,866 |
| Stryker | 9 | $949 |
| Boston Scientific | 6 | $219 |
| AbbVie(2 entities) | 4 | $167 |
| Amgen | 10 | $138 |
| Collegium Pharmaceutical, Inc. | 8 | $130 |
| Biodelivery Sciences International, Inc. | 5 | $123 |
| Abbott | 1 | $107 |
| Pfizer | 2 | $25 |
| Stimwave Technologies Incorporated | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Bioventus LLC | 1 | $12 |
| VGI Medical, LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaSeal$1,429
- ClosureFast$988
- OPTABLATE$845
- SPINEJACK$845
- INTELLIS ADAPTIVESTIM$594
- KYPHON EXPRESS II KYPHOPAK TRAY$159
- VRAYLAR$125
- ETERNA$107
How this compares
$5,776 in reported general payments places this provider in the 75th percentile of 29 interventional pain medicine providers in Arkansas.
See all interventional pain medicine providers in Arkansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 48 | $3,135 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 140 | $2,970 |
| Pregabalin | 39 | $1,064 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $880 |
| Gabapentin | 54 | $761 |
| Morphine Sulfate ErMorphine Sulfate | 21 | $720 |
| Oxycodone Hcl | 46 | $518 |
| Tizanidine Hcl | 52 | $386 |
| Meloxicam | 114 | $376 |
| Tramadol Hcl | 52 | $264 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $252 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Mena
- Sameer JainBryant$56K
- Ryan KrafftMountain Home$51K
- Robert CannonFayetteville$15K
- Amir QureshiLittle Rock$14K
- Brett WhatcottFort Smith$10K
- Mohammad EldeebFort Smith$9K
- Ahmed GhalebLittle Rock$7K
- Majid SaleemLittle Rock$5K
- Gary FrankowskiLittle Rock$5K
- Wolf HeberleinJonesboro$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.